Clinical Trials
2 trialsNCT02192541 2018-03-29
Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT02334319 2016-07-26
Ganetespib Window of Opportunity Study in Head and Neck Cancers
Emory University
Phase 1 Terminated